Open access · OA
via OpenAlex
Alpha‐synuclein repeat variants and survival in Parkinson's disease
Sun Ju Chung, Joanna M. Biernacka, Sebastian M. Armasu, Kari S. Anderson, Roberta Frigerio, Jan Olav Aasly, Grazia Annesi, Anna Rita Bentivoglio, Laura Brighina, Marie‐Christine Chartier‐Harlin, Stefano Goldwurm, Georgios M. Hadjigeorgiou, Barbara Jasińska‐Myga, Beom Seok Jeon, Yun Joong Kim
Movement Disorders · 2014 · ▲ 14 citations
Abstract
OBJECTIVES: To determine whether α-synuclein dinucleotide repeat (REP1) genotypes are associated with survival in Parkinson's disease (PD). METHODS: Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium provided REP1 genotypes and baseline and follow-up clinical data for cases. The primary outcome was time to death. Cox proportional hazards regression models were used to assess the association of REP1 genotypes with survival. RESULTS: Twenty-one sites contributed data for 6,154 cases. There was no significant association between α-synuclein REP1 genotypes and survival in PD. However, there was a significant association between REP1 genotypes and age at onset of PD (hazard ratio: 1.06; 95% confidence interval: 1.01-1.10; P value = 0.01). CONCLUSIONS: In our large consortium study, α-synuclein REP1 genotypes were not associated with survival in PD. Further studies of α-synuclein's role in disease progression and long-term outcomes are needed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/mds.25841
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Chung, S.J., Biernacka, J.M., Armasu, S.M., Anderson, K.S., Frigerio, R., Aasly, J.O., Annesi, G., Bentivoglio, A.R., Brighina, L., Chartier‐Harlin, M., Goldwurm, S., Hadjigeorgiou, G.M., Jasińska‐Myga, B., Jeon, B.S., Kim, Y.J., Krüger, R., Lesage, S., Markopoulou, K., Mellick, G.D., & Morrison, K.E. (2014). Alpha‐synuclein repeat variants and survival in Parkinson's disease. <em>Movement Disorders</em>. https://doi.org/10.1002/mds.25841
Vancouver
Chung SJ, Biernacka JM, Armasu SM, Anderson KS, Frigerio R, Aasly JO, et al. Alpha‐synuclein repeat variants and survival in Parkinson's disease. Movement Disorders. 2014. doi:10.1002/mds.25841.
BibTeX
@article{sun2014Alphas,
title = {Alpha‐synuclein repeat variants and survival in Parkinson's disease},
author = {Sun Ju Chung and Joanna M. Biernacka and Sebastian M. Armasu and Kari S. Anderson and Roberta Frigerio and Jan Olav Aasly and Grazia Annesi and Anna Rita Bentivoglio and Laura Brighina and Marie‐Christine Chartier‐Harlin and Stefano Goldwurm and Georgios M. Hadjigeorgiou and Barbara Jasińska‐Myga and Beom Seok Jeon and Yun Joong Kim and Rejko Krüger and Suzanne Lesage and Katerina Markopoulou and George D. Mellick and Karen E. Morrison and Andreas Puschmann and Eng‐King Tan and David Crosiers and Jessie Theuns and Christine Van Broeckhoven},
journal = {Movement Disorders},
year = {2014},
doi = {10.1002/mds.25841},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
JAMA 2006
Preprint · CC-BY
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
PLoS ONE 2013
Open access · CC-BY
Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration
2022
Open access · OA
Inflammatory Biomarker Levels and Vaccine Response
Biomarker Insights 2021
Open access · CC-BY
IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid
BMC Neurology 2017
Open access · CC-BY
Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels
Nutrition Journal 2020
Open access · CC-BY